The Procter & Gamble Company (NYSE:PG) Shares Acquired by IFM Investors Pty Ltd

IFM Investors Pty Ltd increased its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 1.2% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 479,802 shares of the company’s stock after acquiring an additional 5,469 shares during the period. Procter & Gamble makes up about 0.8% of IFM Investors Pty Ltd’s portfolio, making the stock its 17th largest holding. IFM Investors Pty Ltd’s holdings in Procter & Gamble were worth $83,102,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Itau Unibanco Holding S.A. acquired a new stake in Procter & Gamble in the 2nd quarter valued at about $28,000. Fairway Wealth LLC acquired a new stake in shares of Procter & Gamble in the second quarter valued at approximately $29,000. Ruedi Wealth Management Inc. lifted its position in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after buying an additional 77 shares in the last quarter. POM Investment Strategies LLC acquired a new position in Procter & Gamble during the second quarter worth $34,000. Finally, Quest Partners LLC purchased a new stake in Procter & Gamble in the 2nd quarter valued at $36,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Up 0.0 %

PG stock opened at $169.64 on Friday. The company’s 50 day moving average price is $171.88 and its 200 day moving average price is $167.45. The firm has a market capitalization of $399.51 billion, a price-to-earnings ratio of 29.25, a PEG ratio of 3.67 and a beta of 0.41. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $177.94. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the previous year, the business earned $1.83 EPS. Procter & Gamble’s revenue for the quarter was down .6% on a year-over-year basis. On average, equities research analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.37%. Procter & Gamble’s payout ratio is currently 69.48%.

Wall Street Analyst Weigh In

PG has been the topic of several recent research reports. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. DA Davidson increased their price target on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research note on Monday. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a research report on Monday. TD Cowen assumed coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective for the company. Finally, Morgan Stanley upped their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday. Nine analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $177.00.

Read Our Latest Analysis on PG

Insider Activity

In related news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 385,186 shares of company stock worth $65,479,358. Corporate insiders own 0.18% of the company’s stock.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.